首页 产品目录 分子砌块 按反应类型 1,2,4-三唑 ((19S,22S,28S,34S,40S)-19-(3-氨基-3-氧代丙基)-49-苄基-28-((S)-仲丁基)-34-(羧甲基)-52-((S)-2-((S)-2-((S)-5-胍基-2-((S)-5-胍基-2-((S)-2-((S)-3-羟基-2-(5-((3aS,4S,6aR)-2-氧代六氢-1H-噻吩并[3,4-d]咪唑-4-基)戊酰氨基)丙酰氨基)-4-甲基戊酰氨基)戊酰氨基)戊酰氨基)-3-羟基丙酰氨基)-3-羟基丙酰氨基)-31,40-双(3-胍基丙基)-16-(羟甲基)-10-异丁基-22-甲基-37-(2-(甲硫基)乙基)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-十六氧代-1,2-二硫杂-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-十六氮杂环三十五烷-4-羰基)-L-天冬酰-L-丝酰-L-苯丙氨酰-L-精氨酰-L-酪氨酸

((19S,22S,28S,34S,40S)-19-(3-氨基-3-氧代丙基)-49-苄基-28-((S)-仲丁基)-34-(羧甲基)-52-((S)-2-((S)-2-((S)-5-胍基-2-((S)-5-胍基-2-((S)-2-((S)-3-羟基-2-(5-((3aS,4S,6aR)-2-氧代六氢-1H-噻吩并[3,4-d]咪唑-4-基)戊酰氨基)丙酰氨基)-4-甲基戊酰氨基)戊酰氨基)戊酰氨基)-3-羟基丙酰氨基)-3-羟基丙酰氨基)-31,40-双(3-胍基丙基)-16-(羟甲基)-10-异丁基-22-甲基-37-(2-(甲硫基)乙基)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-十六氧代-1,2-二硫杂-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-十六氮杂环三十五烷-4-羰基)-L-天冬酰-L-丝酰-L-苯丙氨酰-L-精氨酰-L-酪氨酸

((19S,22S,28S,34S,40S)-19-(3-amino-3-oxopropyl)-49-benzyl-28-((S)-sec-butyl)-34-(carboxymethyl)-52-((S)-2-((S)-2-((S)-5-guanidino-2-((S)-5-guanidino-2-((S)-2-((S)-3-hydroxy-2-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)propanamido)-4-methylpentanamido)pentanamido)pentanamido)-3-hydroxypropanamido)-3-hydroxypropanamido)-31,40-bis(3-guanidinopropyl)-16-(hydroxymethyl)-10-isobutyl-22-methyl-37-(2-(methylthio)ethyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecaazacyclotripentacontane-4-carbonyl)-L-asparaginyl-L-seryl-L-phenylalanyl-L-arginyl-L-tyrosine

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

1815618-06-4

中文名称

((19S,22S,28S,34S,40S)-19-(3-氨基-3-氧代丙基)-49-苄基-28-((S)-仲丁基)-34-(羧甲基)-52-((S)-2-((S)-2-((S)-5-胍基-2-((S)-5-胍基-2-((S)-2-((S)-3-羟基-2-(5-((3aS,4S,6aR)-2-氧代六氢-1H-噻吩并[3,4-d]咪唑-4-基)戊酰氨基)丙酰氨基)-4-甲基戊酰氨基)戊酰氨基)戊酰氨基)-3-羟基丙酰氨基)-3-羟基丙酰氨基)-31,40-双(3-胍基丙基)-16-(羟甲基)-10-异丁基-22-甲基-37-(2-(甲硫基)乙基)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-十六氧代-1,2-二硫杂-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-十六氮杂环三十五烷-4-羰基)-L-天冬酰-L-丝酰-L-苯丙氨酰-L-精氨酰-L-酪氨酸

英文名称

((19S,22S,28S,34S,40S)-19-(3-amino-3-oxopropyl)-49-benzyl-28-((S)-sec-butyl)-34-(carboxymethyl)-52-((S)-2-((S)-2-((S)-5-guanidino-2-((S)-5-guanidino-2-((S)-2-((S)-3-hydroxy-2-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)propanamido)-4-methylpentanamido)pentanamido)pentanamido)-3-hydroxypropanamido)-3-hydroxypropanamido)-31,40-bis(3-guanidinopropyl)-16-(hydroxymethyl)-10-isobutyl-22-methyl-37-(2-(methylthio)ethyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecaazacyclotripentacontane-4-carbonyl)-L-asparaginyl-L-seryl-L-phenylalanyl-L-arginyl-L-tyrosine

别名

Biotinyl-Atrial Natriuretic Factor (1-28) (human);L-Tyrosine, N-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-L-seryl-L-leucyl-L-arginyl-L-arginyl-L-seryl-L-seryl-L-cysteinyl-L-phenylalanylglycylglycyl-L-arginyl-L-methionyl-L-α-aspartyl-L-arginyl-L-isoleucylglycyl-L-alanyl-L-glutaminyl-L-serylglycyl-L-leucylglycyl-L-c...;L-Tyrosine, N-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-L-seryl-L-leucyl-L-arginyl-L-arginyl-L-seryl-L-seryl-L-cysteinyl-L-phenylalanylglycylglycyl-L-arginyl-L-methionyl-L-α-aspartyl-L-arginyl-L-isoleucylglycyl-L-alanyl-L-glutaminyl-L-serylglycyl-L-leucylglycyl-L-cysteinyl-L-asparaginyl-L-seryl-L-phenylalanyl-L-arginyl-, cyclic (7→23)-disulfide;Atrial Natriuretic Peptide (1-28), human, porcine, Biotin-labeled - 0.5 mg

标准英文名

((19S,22S,28S,34S,40S)-19-(3-amino-3-oxopropyl)-49-benzyl-28-((S)-sec-butyl)-34-(carboxymethyl)-52-((S)-2-((S)-2-((S)-5-guanidino-2-((S)-5-guanidino-2-((S)-2-((S)-3-hydroxy-2-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)propanamido)-4-methylpentanamido)pentanamido)pentanamido)-3-hydroxypropanamido)-3-hydroxypropanamido)-31,40-bis(3-guanidinopropyl)-16-(hydroxymethyl)-10-isobutyl-22-methyl-37-(2-(methylthio)ethyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecaazacyclotripentacontane-4-carbonyl)-L-asparaginyl-L-seryl-L-phenylalanyl-L-arginyl-L-tyrosine

分子式

C137H217N47O41S4

分子量

3306.80

精确分子量

3304.52

SMILES

CC[C@H](C)[C@@H]1NC(=O)C(CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)C(CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)NC(=O)C(NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@@H]32)CSSCC(C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)O)NC(=O)CNC(=O)C(CC(C)C)NC(=O)CNC(=O)C(CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)CNC1=O

标准SMILES

CSCCC1NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)CNC(=O)C(CC2C=CC=CC=2)NC(=O)C(CSSCC(NC(=O)CNC(=O)C(CC(C)C)NC(=O)CNC(=O)C(CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)C(CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC1=O)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12

用途

Potential use in cardiovascular disease research; regulation of fluid homeostasis and blood pressure as an endocrine-acting natriuretic peptide.

InChIKey

HDTMXJVYSAVVRC-STPZZZDRSA-N

安全信息

SureRoute逆合成路线

1.  1815618-06-4 逆合成路线 1

—
—
ACIWMV449
1815618-06-4
来源: SureRoute

2.  1815618-06-4 逆合成路线 2

—
—
ACIWMV449
1815618-06-4
来源: SureRoute

3.  1815618-06-4 逆合成路线 3

—
—
ACIWMV449
1815618-06-4
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手